123 related articles for article (PubMed ID: 9928353)
1. Transplant-mediated locomotion is improved by selective serotonergic agonists.
Yi DK; Adipudi V; Shibayama M; Anderson KN; Simansky KJ; Murray M
Ann N Y Acad Sci; 1998 Nov; 860():524-7. PubMed ID: 9928353
[No Abstract] [Full Text] [Related]
2. Direct agonists for serotonin receptors enhance locomotor function in rats that received neural transplants after neonatal spinal transection.
Kim D; Adipudi V; Shibayama M; Giszter S; Tessler A; Murray M; Simansky KJ
J Neurosci; 1999 Jul; 19(14):6213-24. PubMed ID: 10407057
[TBL] [Abstract][Full Text] [Related]
3. L-DOPA and quipazine elicit air-stepping in neonatal rats with spinal cord transections.
McEwen ML; Van Hartesveldt C; Stehouwer DJ
Behav Neurosci; 1997 Aug; 111(4):825-33. PubMed ID: 9267660
[TBL] [Abstract][Full Text] [Related]
4. 5-HT1A receptors are involved in short- and long-term processes responsible for 5-HT-induced locomotor function recovery in chronic spinal rat.
Antri M; Mouffle C; Orsal D; Barthe JY
Eur J Neurosci; 2003 Oct; 18(7):1963-72. PubMed ID: 14622228
[TBL] [Abstract][Full Text] [Related]
5. The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin.
Sills TL; Greenshaw AJ; Baker GB; Fletcher PJ
Psychopharmacology (Berl); 1999 Apr; 143(4):426-32. PubMed ID: 10367561
[TBL] [Abstract][Full Text] [Related]
6. Effects of standardized extracts of St. John's wort on the single-unit activity of serotonergic dorsal Raphe neurons in awake cats: comparisons with fluoxetine and sertraline.
Fornal CA; Metzler CW; Mirescu C; Stein SK; Jacobs BL
Neuropsychopharmacology; 2001 Dec; 25(6):858-70. PubMed ID: 11750179
[TBL] [Abstract][Full Text] [Related]
7. Locomotor recovery in the chronic spinal rat: effects of long-term treatment with a 5-HT2 agonist.
Antri M; Orsal D; Barthe JY
Eur J Neurosci; 2002 Aug; 16(3):467-76. PubMed ID: 12193190
[TBL] [Abstract][Full Text] [Related]
8. Indirect serotonergic agonists attenuate neuronal opiate withdrawal.
Akaoka H; Aston-Jones G
Neuroscience; 1993 Jun; 54(3):561-5. PubMed ID: 8332249
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic activation of locomotor behavior and posture in one-day old rats.
Swann HE; Kempe RB; Van Orden AM; Brumley MR
Behav Brain Res; 2016 Apr; 302():104-14. PubMed ID: 26795091
[TBL] [Abstract][Full Text] [Related]
10. Sensory feedback modulates quipazine-induced stepping behavior in the newborn rat.
Brumley MR; Roberto ME; Strain MM
Behav Brain Res; 2012 Apr; 229(1):257-64. PubMed ID: 22249136
[TBL] [Abstract][Full Text] [Related]
11. Development of autonomic dysreflexia after spinal cord injury is associated with a lack of serotonergic axons in the intermediolateral cell column.
Cormier CM; Mukhida K; Walker G; Marsh DR
J Neurotrauma; 2010 Oct; 27(10):1805-18. PubMed ID: 20698759
[TBL] [Abstract][Full Text] [Related]
12. Morphofunctional study of injured spinal cord of rats after activation of serotonergic receptors and motor load.
Gilerovich EG; Moshonkina TR; Pavlova NV; Otellin VA; Gerasimenko YP
Dokl Biol Sci; 2009; 428():412-5. PubMed ID: 19994777
[No Abstract] [Full Text] [Related]
13. Evidence for serotonin sensitivity of adult rat spinal axons: studies using randomized double pulse stimulation.
Saruhashi Y; Young W; Sugimori M; Abrahams J; Sakuma J
Neuroscience; 1997 Sep; 80(2):559-66. PubMed ID: 9284357
[TBL] [Abstract][Full Text] [Related]
14. [Serotoninergic system morphofunctional aspects in control of postural and locomotion function].
Gerasimenko IuP; Moshonkina TR; Pavlova NV; Tomilovskaia ES; Kozlovskaia IB
Ross Fiziol Zh Im I M Sechenova; 2012 Dec; 98(12):1595-603. PubMed ID: 23461203
[TBL] [Abstract][Full Text] [Related]
15. Range of motion (ROM) restriction influences quipazine-induced stepping behavior in postnatal day one and day ten rats.
Strain MM; Brumley MR
Behav Brain Res; 2014 Nov; 274():365-81. PubMed ID: 25151623
[TBL] [Abstract][Full Text] [Related]
16. Recovery of locomotion after ventral and ventrolateral spinal lesions in the cat. II. Effects of noradrenergic and serotoninergic drugs.
Brustein E; Rossignol S
J Neurophysiol; 1999 Apr; 81(4):1513-30. PubMed ID: 10200188
[TBL] [Abstract][Full Text] [Related]
17. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
Carlton J; Rowland N
Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma prolactin levels induced in rats by d-fenfluramine: relation to central serotonergic stimulation.
Quattrone A; Di Renzo G; Schettini G; Tedeschi G; Scopacasa F
Eur J Pharmacol; 1978 May; 49(2):163-7. PubMed ID: 149011
[TBL] [Abstract][Full Text] [Related]
19. MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro.
Biello SM; Dafters RI
Brain Res; 2001 Nov; 920(1-2):202-9. PubMed ID: 11716826
[TBL] [Abstract][Full Text] [Related]
20. Serotonin controls initiation of locomotion and afferent modulation of coordination via 5-HT
Cabaj AM; Majczyński H; Couto E; Gardiner PF; Stecina K; Sławińska U; Jordan LM
J Physiol; 2017 Jan; 595(1):301-320. PubMed ID: 27393215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
